The Trump administration is looking for input on whether marijuana should be reclassified under international drug control treaties.
Comments must be submitted by April 23, 2018.
The FDA is asking "interested persons" to send in comments, "concerning abuse potential, actual abuse, medical usefulness, trafficking, and impact of scheduling changes on availability for medical use."
Right now under both U.S. law, and global agreements, marijuana is in the most restrictive category of Schedule I. Which means that research on marijuana is restricted, and it is not available for formal prescriptions. In the United States this means that cannabis has "no currently accepted medical use and a high potential for abuse." Globally, Schedule I means nations signed onto drug treaties are not supposed to legalize it.
The United Nations World Health Organization (WHO) is expected to review the current international classification of marijuana, THC, cannabidiol, and other compounds. After more analysis, depending on what they find, cannabis could be rescheduled internationally. This would give momentum to efforts to change marijuana's status in the United States and other countries.
Marijuana hast' been under formal review since first being placed in Schedule I of the international agreement since 1961.
